3

MAIN DOCUMENT DESCRIPTION

Company: Niagen Bioscience, Inc.
Filed: June 25, 2008
Period of Report: June 25, 2008
Accession Number: 0001209191-08-038917

View Document ↗ View on SEC.gov ↗